# OnCo record paper-cercek-dostarlimab-rectal-nejm-2022 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: .
@prefix onco: .
@prefix xsd: .
a schema:ScholarlyArticle ;
onco:kind "paper" ;
schema:identifier "paper-cercek-dostarlimab-rectal-nejm-2022" ;
schema:name "Cercek 2022: six months of dostarlimab alone made rectal cancer disappear in every patient with mismatch-repair deficiency"@en ;
schema:description "All 12 patients with locally advanced dMMR rectal cancer had a complete clinical response to a PD-1 antibody alone, avoiding chemotherapy, radiotherapy and surgery."@en ;
schema:url ;
schema:dateModified "2026-09-08"^^xsd:date ;
schema:citation , ;
schema:sameAs ;
schema:datePublished "2022"^^xsd:gYear ;
schema:author "Cercek A, Lumish M, Sinopoli J, et al." ;
onco:related , , , , , ;
onco:cancers ;
onco:technologies , , ;
onco:targets , ;
onco:drugs , ;
onco:companies ;
onco:institutions ;
onco:pathways , ;
onco:terms , , , ;
onco:people , ;
onco:bottlenecks , , ;
onco:journals .